IART

SEC source: 0001209191-18-019823 · doc4.xml · nonDerivative · entry 3

Arduini Peter J · CIK 0001323134 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 165,604

SEC source: 0001209191-18-019823 · doc4.xml · nonDerivative · entry 2

Arduini Peter J · CIK 0001323134 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 165,894

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001209191-18-019823 · doc4.xml · nonDerivative · entry 1

Arduini Peter J · CIK 0001323134 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 165,604

SEC source: 0001209191-18-021065 · doc4.xml · nonDerivative · entry 1

MOORADIAN JOHN · CIK 0001563593 · Corp VP, Global Ops & Supp Chn

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,661

SEC source: 0001209191-18-018861 · doc4.xml · nonDerivative · entry 1

VINHAIS JOSEPH · CIK 0001563599 · Corp VP, Global Qlty Assurance

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,660

F1 · price: The price shown above represents the weighted average price of the shares sold. The range of sale prices was $54.1 to $54.15.

SEC source: 0001209191-18-018856 · doc4.xml · derivative · entry 9

CARUSO RICHARD E · CIK 0001187576 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 20,878 shares

Expires 2018-05-19

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: 25% of the stock options vest every quarter from the grant date of 5/19/2010

F5 · balance_after: In accordance with the terms of the stock option plan, the exercise price of the option and number of shares subject to the option have been adjusted to reflect the two-for-one stock split that occurred on December 21, 2016.

F6 · balance_after: This option was previously reported as covering 10,000 shares at an exercise price of $41.75 per share, but was adjusted pursuant to the anti-dilution provisions of the award in connection with the spin-off of SeaSpine Holdings Corporation on July 1, 2015 to 10,439 shares of common stock at an exercise price of $36.12 per share.

SEC source: 0001209191-18-018856 · doc4.xml · derivative · entry 8

CARUSO RICHARD E · CIK 0001187576 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 12,002 shares

Expires 2018-05-19

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: 25% of the stock options vest every quarter from the grant date of 5/19/2010

F4 · balance_after: This option was previously reported as covering 5,749 shares at an exercise price of $41.75 per share, but was adjusted pursuant to the anti-dilution provisions of the award in connection with the spin-off of SeaSpine Holdings Corporation on July 1, 2015 to 6,001 shares of common stock at an exercise price of $36.12 per share.

F5 · balance_after: In accordance with the terms of the stock option plan, the exercise price of the option and number of shares subject to the option have been adjusted to reflect the two-for-one stock split that occurred on December 21, 2016.

SEC source: 0001209191-18-018856 · doc4.xml · nonDerivative · entry 4

CARUSO RICHARD E · CIK 0001187576 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 134,134

F2 · price: The price shown above represents the weighted average price of the shares sold. The range of sale prices was $53.37 to $54.

SEC source: 0001209191-18-018856 · doc4.xml · nonDerivative · entry 3

CARUSO RICHARD E · CIK 0001187576 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 155,012

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001209191-18-018856 · doc4.xml · nonDerivative · entry 2

CARUSO RICHARD E · CIK 0001187576 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 134,134

F2 · price: The price shown above represents the weighted average price of the shares sold. The range of sale prices was $53.37 to $54.

SEC source: 0001209191-18-018856 · doc4.xml · nonDerivative · entry 1

CARUSO RICHARD E · CIK 0001187576 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 146,136

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: On December 21, 2016, the common stock of Integra LifeSciences Holdings Corporation split two-for-one, resulting in the reporting person's ownership of one additional share of common stock for each share of common stock owned as of that date, as reflected in the totals listed on this Form 4.

SEC source: 0001209191-18-018014 · doc4.xml · derivative · entry 3

SULLIVAN JAMES M · CIK 0001210128 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 15,658 shares

Expires 2018-05-19

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: 25% of the stock options vest every quarter from the grant date of 5/19/2010

F3 · balance_after: This option was previously reported as covering 7,500 shares at an exercise price of $41.75 per share, but was adjusted pursuant to the anti-dilution provisions of the award in connection with the spin-off of SeaSpine Holdings Corporation on July 1, 2015 to 7,829 shares of common stock at an exercise price of $36.12 per share.

F4 · balance_after: In accordance with the terms of the stock option plan, the exercise price of the option and number of shares subject to the option have been adjusted to reflect the two-for-one stock split that occurred on December 21, 2016.

SEC source: 0001209191-18-018014 · doc4.xml · nonDerivative · entry 2

SULLIVAN JAMES M · CIK 0001210128 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 59,604

F1 · price: The price shown above represents the weighted average price of the shares sold. The range of sale prices was $52.44 to $52.69.

SEC source: 0001209191-18-018014 · doc4.xml · nonDerivative · entry 1

SULLIVAN JAMES M · CIK 0001210128 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 75,262

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001209191-18-017221 · doc4.xml · derivative · entry 3

SCHADE CHRISTIAN S · CIK 0001214496 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 15,658 shares

Expires 2018-05-19

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: 25% of the stock options vest every quarter from the grant date of 5/19/2010

F3 · balance_after: This option was previously reported as covering 7,500 shares at an exercise price of $41.75 per share, but was adjusted pursuant to the anti-dilution provisions of the award in connection with the spin-off of SeaSpine Holdings Corporation on July 1, 2015 to 7,829 shares of common stock at an exercise price of $36.12 per share.

F4 · balance_after: In accordance with the terms of the stock option plan, the exercise price of the option and number of shares subject to the option have been adjusted to reflect the two-for-one stock split that occurred on December 21, 2016.

SEC source: 0001209191-18-017221 · doc4.xml · nonDerivative · entry 2

SCHADE CHRISTIAN S · CIK 0001214496 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 29,668

F1 · price: The price shown above represents the weighted average price of the shares sold. The range of sale prices was $52.73 to $53.04.

SEC source: 0001209191-18-017221 · doc4.xml · nonDerivative · entry 1

SCHADE CHRISTIAN S · CIK 0001214496 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 45,326

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001209191-18-013864 · doc4.xml · derivative · entry 5

BRADLEY KEITH · CIK 0001188650 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 15,658 shares

Expires 2018-05-19

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person.

F3 · derivative.exercise_date: 25% of the stock options vest every quarter from the grant date of 5/19/2010.

F4 · balance_after: This option was previously reported as covering 7,500 shares at an exercise price of $41.75 per share, but was adjusted pursuant to the anti-dilution provisions of the award in connection with the spin-off of SeaSpine Holdings Corporation on July 1, 2015 to 7,829 shares of common stock at an exercise price of $36.12 per share.

F5 · balance_after: In accordance with the terms of the stock option plan, the exercise price of the option and number of shares subject to the option have been adjusted to reflect the two-for-one stock split that occurred on December 21, 2016.

SEC source: 0001209191-18-013864 · doc4.xml · nonDerivative · entry 4

BRADLEY KEITH · CIK 0001188650 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 37,065

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person.

F2 · price: The price shown above represents the weighted average price of the shares sold. The range of sale prices was $55 to $55.02.

SEC source: 0001209191-18-013864 · doc4.xml · nonDerivative · entry 3

BRADLEY KEITH · CIK 0001188650 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 52,723

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person.

SEC source: 0001209191-18-013864 · doc4.xml · nonDerivative · entry 2

BRADLEY KEITH · CIK 0001188650 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 37,065

SEC source: 0001209191-18-013864 · doc4.xml · nonDerivative · entry 1

BRADLEY KEITH · CIK 0001188650 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 37,074

SEC source: 0001209191-18-011393 · doc4.xml · nonDerivative · entry 3

VINHAIS JOSEPH · CIK 0001563599 · Corp VP, Global Qlty Assurance

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,460

F3 · shares: On February 15, 2018, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2017, at least 3% and up to a maximum of 11% increase in annual revenue over the prior fiscal year, under the March 13, 2017 Performance Stock Award. Accordingly, 33% of the shares will vest on March 13, 2018 at 150% target, the first anniversary of the grant date.

SEC source: 0001209191-18-011393 · doc4.xml · nonDerivative · entry 2

VINHAIS JOSEPH · CIK 0001563599 · Corp VP, Global Qlty Assurance

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,611

F2 · shares: On February 15, 2018, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2017, at least 3% and up to a maximum of 11% increase in annual revenue over the prior fiscal year, under the March 14, 2016 Performance Stock Award. Accordingly, 33% of the shares will vest on March 14, 2018 at 150% target, the second anniversary of the grant date.

SEC source: 0001209191-18-011393 · doc4.xml · nonDerivative · entry 1

VINHAIS JOSEPH · CIK 0001563599 · Corp VP, Global Qlty Assurance

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,669

F1 · shares: On February 15, 2018, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2017, at least a 3% increase in annual revenue over the prior fiscal year, under the March 23, 2015 Performance Stock Award. Accordingly, 34% of the shares will vest on March 23, 2018, the third anniversary of the grant date.

SEC source: 0001209191-18-011392 · doc4.xml · nonDerivative · entry 3

REUVERS DANIEL L. · CIK 0001563602 · CVP,PRES - CODMAN SPC SURGICAL

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,798

F3 · shares: On February 15, 2018, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2017, at least 3% and up to a maximum of 11% increase in annual revenue over the prior fiscal year, under the March 13, 2017 Performance Stock Award. Accordingly, 33% of the shares will vest on March 13, 2018 at 150% target, the first anniversary of the grant date.

SEC source: 0001209191-18-011392 · doc4.xml · nonDerivative · entry 2

REUVERS DANIEL L. · CIK 0001563602 · CVP,PRES - CODMAN SPC SURGICAL

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,674

F2 · shares: On February 15, 2018, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2017, at least 3% and up to a maximum of 11% increase in annual revenue over the prior fiscal year, under the March 14, 2016 Performance Stock Award. Accordingly, 33% of the shares will vest on March 14, 2018 at 150% target, the second anniversary of the grant date.

SEC source: 0001209191-18-011392 · doc4.xml · nonDerivative · entry 1

REUVERS DANIEL L. · CIK 0001563602 · CVP,PRES - CODMAN SPC SURGICAL

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,222

F1 · shares: On February 15, 2018, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2017, at least a 3% increase in annual revenue over the prior fiscal year, under the March 23, 2015 Performance Stock Award. Accordingly, 34% of the shares will vest on March 23, 2018, the third anniversary of the grant date.

SEC source: 0001209191-18-011390 · doc4.xml · nonDerivative · entry 3

OGRADY JUDITH · CIK 0001187573 · CorpVP,Global Reg.Affairs

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,813

F3 · shares: On February 15, 2018, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2017, at least 3% and up to a maximum of 11% increase in annual revenue over the prior fiscal year, under the March 13, 2017 Performance Stock Award. Accordingly, 33% of the shares will vest on March 13, 2018 at 150% target, the first anniversary of the grant date.

SEC source: 0001209191-18-011390 · doc4.xml · nonDerivative · entry 2

OGRADY JUDITH · CIK 0001187573 · CorpVP,Global Reg.Affairs

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,105

F2 · shares: On February 15, 2018, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2017, at least 3% and up to a maximum of 11% increase in annual revenue over the prior fiscal year, under the March 14, 2016 Performance Stock Award. Accordingly, 33% of the shares will vest on March 14, 2018 at 150% target, the second anniversary of the grant date.

SEC source: 0001209191-18-011390 · doc4.xml · nonDerivative · entry 1

OGRADY JUDITH · CIK 0001187573 · CorpVP,Global Reg.Affairs

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,331

F1 · shares: On February 15, 2018, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2017, at least a 3% increase in annual revenue over the prior fiscal year, under the March 23, 2015 Performance Stock Award. Accordingly, 34% of the shares will vest on March 23, 2018, the third anniversary of the grant date.

SEC source: 0001209191-18-011389 · doc4.xml · nonDerivative · entry 2

Mosebrook Jeffrey · CIK 0001719686 · Principal Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,107

F2 · shares: On February 15, 2018, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2017, at least 3% and up to a maximum of 11% increase in annual revenue over the prior fiscal year, under the March 14, 2016 Performance Stock Award. Accordingly, 33% of the shares will vest on March 14, 2018 at 150% target, the second anniversary of the grant date.

SEC source: 0001209191-18-011389 · doc4.xml · nonDerivative · entry 1

Mosebrook Jeffrey · CIK 0001719686 · Principal Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,471

F1 · shares: On February 15, 2018, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2017, at least a 3% increase in annual revenue over the prior fiscal year, under the March 23, 2015 Performance Stock Award. Accordingly, 34% of the shares will vest on March 23, 2018, the third anniversary of the grant date.

SEC source: 0001209191-18-011355 · doc4.xml · nonDerivative · entry 3

MOORADIAN JOHN · CIK 0001563593 · Corp VP, Global Ops & Supp Chn

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,187

F3 · shares: On February 15, 2018, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2017, at least 3% and up to a maximum of 11% increase in annual revenue over the prior fiscal year, under the March 13, 2017 Performance Stock Award. Accordingly, 33% of the shares will vest on March 13, 2018 at 150% target, the first anniversary of the grant date.

SEC source: 0001209191-18-011355 · doc4.xml · nonDerivative · entry 2

MOORADIAN JOHN · CIK 0001563593 · Corp VP, Global Ops & Supp Chn

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,112

F2 · shares: On February 15, 2018, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2017, at least 3% and up to a maximum of 11% increase in annual revenue over the prior fiscal year, under the March 14, 2016 Performance Stock Award. Accordingly, 33% of the shares will vest on March 14, 2018 at 150% target, the second anniversary of the grant date.

SEC source: 0001209191-18-011355 · doc4.xml · nonDerivative · entry 1

MOORADIAN JOHN · CIK 0001563593 · Corp VP, Global Ops & Supp Chn

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,819

F1 · shares: On February 15, 2018, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2017, at least a 3% increase in annual revenue over the prior fiscal year, under the March 23, 2015 Performance Stock Award. Accordingly, 34% of the shares will vest on March 23, 2018, the third anniversary of the grant date.

SEC source: 0001209191-18-011354 · doc4.xml · nonDerivative · entry 3

GORELICK RICHARD D. · CIK 0001563554 · Corp VP, Gen Counsel & Sec

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,399

F3 · shares: On February 15, 2018, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2017, at least 3% and up to a maximum of 11% increase in annual revenue over the prior fiscal year, under the March 13, 2017 Performance Stock Award. Accordingly, 33% of the shares will vest on March 13, 2018 at 150% target, the first anniversary of the grant date.

SEC source: 0001209191-18-011354 · doc4.xml · nonDerivative · entry 2

GORELICK RICHARD D. · CIK 0001563554 · Corp VP, Gen Counsel & Sec

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,616

F2 · shares: On February 15, 2018, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2017, at least 3% and up to a maximum of 11% increase in annual revenue over the prior fiscal year, under the March 14, 2016 Performance Stock Award. Accordingly, 33% of the shares will vest on March 14, 2018 at 150% target, the second anniversary of the grant date.

SEC source: 0001209191-18-011354 · doc4.xml · nonDerivative · entry 1

GORELICK RICHARD D. · CIK 0001563554 · Corp VP, Gen Counsel & Sec

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,609

F1 · shares: On February 15, 2018, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2017, at least a 3% increase in annual revenue over the prior fiscal year, under the March 23, 2015 Performance Stock Award. Accordingly, 34% of the shares will vest on March 23, 2018, the third anniversary of the grant date.

SEC source: 0001209191-18-011353 · doc4.xml · nonDerivative · entry 2

Evoli Lisa · CIK 0001661715 · Chief Human Resources Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,222

F2 · shares: On February 15, 2018, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2017, at least 3% and up to a maximum of 11% increase in annual revenue over the prior fiscal year, under the March 13, 2017 Performance Stock Award. Accordingly, 33% of the shares will vest on March 13, 2018 at 150% target, the first anniversary of the grant date.

SEC source: 0001209191-18-011353 · doc4.xml · nonDerivative · entry 1

Evoli Lisa · CIK 0001661715 · Chief Human Resources Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,835

F1 · shares: On February 15, 2018, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2017, at least 3% and up to a maximum of 11% increase in annual revenue over the prior fiscal year, under the March 14, 2016 Performance Stock Award. Accordingly, 33% of the shares will vest on March 14, 2018 at 150% target, the second anniversary of the grant date.

SEC source: 0001209191-18-011349 · doc4.xml · nonDerivative · entry 3

DAVIS ROBERT T. JR. · CIK 0001563606 · CVP,PRES-ORTHO & TISSUE TECH

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 42,407

F3 · shares: On February 15, 2018, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2017, at least 3% and up to a maximum of 11% increase in annual revenue over the prior fiscal year, under the March 13, 2017 Performance Stock Award. Accordingly, 33% of the shares will vest on March 13, 2018 at 150% target, the first anniversary of the grant date.

SEC source: 0001209191-18-011349 · doc4.xml · nonDerivative · entry 2

DAVIS ROBERT T. JR. · CIK 0001563606 · CVP,PRES-ORTHO & TISSUE TECH

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 38,866

F2 · shares: On February 15, 2018, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2017, at least 3% and up to a maximum of 11% increase in annual revenue over the prior fiscal year, under the March 14, 2016 Performance Stock Award. Accordingly, 33% of the shares will vest on March 14, 2018 at 150% target, the second anniversary of the grant date.

SEC source: 0001209191-18-011349 · doc4.xml · nonDerivative · entry 1

DAVIS ROBERT T. JR. · CIK 0001563606 · CVP,PRES-ORTHO & TISSUE TECH

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 35,221

F1 · shares: On February 15, 2018, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2017, at least a 3% increase in annual revenue over the prior fiscal year, under the March 23, 2015 Performance Stock Award. Accordingly, 34% of the shares will vest on March 23, 2018, the third anniversary of the grant date.

SEC source: 0001209191-18-011346 · doc4.xml · nonDerivative · entry 4

Coleman Glenn · CIK 0001434369 · CVP, CHIEF FINANCIAL OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 42,374

F4 · shares: On February 15, 2018, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2017, at least 3% and up to a maximum of 11% increase in annual revenue over the prior fiscal year, under the March 13, 2017 Performance Stock Award. Accordingly, 33% of the shares will vest on March 13, 2018 at 150% target, the first anniversary of the grant date.

SEC source: 0001209191-18-011346 · doc4.xml · nonDerivative · entry 3

Coleman Glenn · CIK 0001434369 · CVP, CHIEF FINANCIAL OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 35,858

F3 · shares: On February 15, 2018, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2017, at least 3% and up to a maximum of 11% increase in annual revenue over the prior fiscal year, under the March 14, 2016 Performance Stock Award. Accordingly, 33% of the shares will vest on March 14, 2018 at 150% target, the second anniversary of the grant date.

SEC source: 0001209191-18-011346 · doc4.xml · nonDerivative · entry 2

Coleman Glenn · CIK 0001434369 · CVP, CHIEF FINANCIAL OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,542

F2 · shares: On February 15, 2018, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2017, at least a 3% increase in annual revenue over the prior fiscal year, under the March 23, 2015 Performance Stock Award. Accordingly, 34% of the shares will vest on March 23, 2018, the third anniversary of the grant date.

SEC source: 0001209191-18-011346 · doc4.xml · nonDerivative · entry 1

Coleman Glenn · CIK 0001434369 · CVP, CHIEF FINANCIAL OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,536

F1 · shares: On February 15, 2018, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2017, at least a 3% increase in annual revenue over the prior fiscal year, under the May 2, 2014 Performance Stock Award. Accordingly, 25% of the shares will vest on May 2, 2018, the fourth anniversary of the grant date.

SEC source: 0001209191-18-011343 · doc4.xml · nonDerivative · entry 3

Burhop Kenneth · CIK 0001601582 · CORPVP,CHIEFSCIENTIFIC OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,688

F3 · shares: On February 15, 2018, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2017, at least 3% and up to a maximum of 11% increase in annual revenue over the prior fiscal year, under the March 13, 2017 Performance Stock Award. Accordingly, 33% of the shares will vest on March 13, 2018 at 150% target, the first anniversary of the grant date.

SEC source: 0001209191-18-011343 · doc4.xml · nonDerivative · entry 2

Burhop Kenneth · CIK 0001601582 · CORPVP,CHIEFSCIENTIFIC OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,425

F2 · shares: On February 15, 2018, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2017, at least 3% and up to a maximum of 11% increase in annual revenue over the prior fiscal year, under the March 14, 2016 Performance Stock Award. Accordingly, 33% of the shares will vest on March 14, 2018 at 150% target, the second anniversary of the grant date.